BIOCAD (Russia)

Recent papers from BIOCAD (Russia)

1. Cell Painting Identifies Phenotypic Clusters Associated with Anticancer Drug Responses in OVCAR-3 Ovarian Cancer CellsInternational Journal of Molecular Sciences · 2026
2. Optimization of 3D Spheroid Models of Ovarian, Breast, and Gastric Cancer for Comparative Screening of Drug CandidatesACS Omega · 2026
3. Final results of the phase III OCTAVA trial: Clinical benefit of low-dose anti–CTLA-4 plus anti–PD-1 combination vs anti–PD-1 monotherapy in unresectable or metastatic melanoma.Journal of Clinical Oncology · 2026
4. Efficacy and safety of the pertuzumab biosimilar BCD-178 versus the originator pertuzumab in patients with HER2-positive locally advanced breast cancer: Results from the international, double-blind, randomized, phase III PREFER trial.Journal of Clinical Oncology · 2026
5. Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: Two-Year Results of the Real Word Evidence LIBRA StudyDoklady Biochemistry and Biophysics · 2026
6. Challenges of modeling pristane‐induced lupus in non‐human primatesAnimal Models and Experimental Medicine · 2026
7. Rigidified cyclic diglycolamides: coordination and extraction of trivalent f-elementsDalton Transactions · 2026
8. Visualization, Data Extraction, and Multiparametric Analysis of 3D Pancreatic and Colorectal Cancer Cell Lines for High-Throughput ScreeningBiomedicines · 2026
9. Arvenacogene sanparvovec: A novel gene therapy for hemophilia B – results from A phase I–II first-in-human trialBlood · 2025
10. Three-Dimensional Tumor Spheroids of Pancreatic and Colorectal Cancer Cell Lines for High-Throughput Screening of Drug CandidatesACS Omega · 2025
11. Changes in the Interaction Properties of Antibodies with Fc Receptors upon Binding to Target AntigensBiosensors · 2025
12. Phenotypic profiling of small molecules using cell painting assay in HCT116 colorectal cancer cellsPLoS ONE · 2025
13. Slowing the progression of ankylosing spondylitis during long-term therapy with netakimab: results of the international multicenter randomized double-blind phase III clinical trial BCD-085-5/ASTERAModern Rheumatology Journal · 2025
14. Evidence synthesis in neuromyelitis optica spectrum disorders: modeling a clinical trial based on published dataReal-World Data & Evidence · 2025
15. Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosisS S Korsakov Journal of Neurology and Psychiatry · 2025
16. Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancerJournal of Modern Oncology · 2025
17. The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTADoklady Biochemistry and Biophysics · 2025
18. Steroid-sparing effect of levilimab in rheumatoid arthritis in real practiceTerapevticheskii arkhiv · 2025
19. The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUSRheumatology Science and Practice · 2025
20. Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancerJournal of Modern Oncology · 2025